FI46849C - Menetelmä terapeuttisesti vaikuttavien 3-hydroksi-3H-1,2-dihydro-1,4-b entsodiatsepiini-2-onien valmistamiseksi. - Google Patents

Menetelmä terapeuttisesti vaikuttavien 3-hydroksi-3H-1,2-dihydro-1,4-b entsodiatsepiini-2-onien valmistamiseksi.

Info

Publication number
FI46849C
FI46849C FI672159A FI215967A FI46849C FI 46849 C FI46849 C FI 46849C FI 672159 A FI672159 A FI 672159A FI 215967 A FI215967 A FI 215967A FI 46849 C FI46849 C FI 46849C
Authority
FI
Finland
Prior art keywords
benzodiazepin
dihydro
hydroxy
ones
preparation
Prior art date
Application number
FI672159A
Other languages
English (en)
Swedish (sv)
Other versions
FI46849B (fi
Inventor
Bell
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Application granted granted Critical
Publication of FI46849B publication Critical patent/FI46849B/fi
Publication of FI46849C publication Critical patent/FI46849C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/46—Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2/00—Addition polymers of aldehydes or cyclic oligomers thereof or of ketones; Addition copolymers thereof with less than 50 molar percent of other substances
    • C08G2/06—Catalysts
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2/00—Addition polymers of aldehydes or cyclic oligomers thereof or of ketones; Addition copolymers thereof with less than 50 molar percent of other substances
    • C08G2/18—Copolymerisation of aldehydes or ketones
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2/00—Addition polymers of aldehydes or cyclic oligomers thereof or of ketones; Addition copolymers thereof with less than 50 molar percent of other substances
    • C08G2/18—Copolymerisation of aldehydes or ketones
    • C08G2/22—Copolymerisation of aldehydes or ketones with epoxy compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polyethers (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI672159A 1961-08-29 1967-08-10 Menetelmä terapeuttisesti vaikuttavien 3-hydroksi-3H-1,2-dihydro-1,4-b entsodiatsepiini-2-onien valmistamiseksi. FI46849C (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13456961A 1961-08-29 1961-08-29
US17717462A 1962-03-05 1962-03-05
US37974064A 1964-07-01 1964-07-01

Publications (2)

Publication Number Publication Date
FI46849B FI46849B (fi) 1973-04-02
FI46849C true FI46849C (fi) 1973-07-10

Family

ID=27384605

Family Applications (4)

Application Number Title Priority Date Filing Date
FI621565A FI46072C (fi) 1961-08-29 1962-08-27 Menetelmä terapeuttisesti vaikuttavien 3-asyylioksi-3H-1,2-dihydro-1,4 -bentsodiatsepiini-2-onien valmistamiseksi.
FI672159A FI46849C (fi) 1961-08-29 1967-08-10 Menetelmä terapeuttisesti vaikuttavien 3-hydroksi-3H-1,2-dihydro-1,4-b entsodiatsepiini-2-onien valmistamiseksi.
FI672158A FI46848C (fi) 1961-08-29 1967-08-10 Menetelmä terapeuttisesti vaikuttavien 3-halogeeni-3H-1,2-dihydro-1,4- bentsodiatsepiini-2-onien valmistamiseksi.
FI682762A FI47371C (fi) 1961-08-29 1968-09-30 Menetelmä 5-aryyli-3-hydroksi-1-alempi alkyyli-1,2-dihydro-3H-1,4-bent sodiatsepiini-2-oni-johdannaisten valmistamiseksi.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FI621565A FI46072C (fi) 1961-08-29 1962-08-27 Menetelmä terapeuttisesti vaikuttavien 3-asyylioksi-3H-1,2-dihydro-1,4 -bentsodiatsepiini-2-onien valmistamiseksi.

Family Applications After (2)

Application Number Title Priority Date Filing Date
FI672158A FI46848C (fi) 1961-08-29 1967-08-10 Menetelmä terapeuttisesti vaikuttavien 3-halogeeni-3H-1,2-dihydro-1,4- bentsodiatsepiini-2-onien valmistamiseksi.
FI682762A FI47371C (fi) 1961-08-29 1968-09-30 Menetelmä 5-aryyli-3-hydroksi-1-alempi alkyyli-1,2-dihydro-3H-1,4-bent sodiatsepiini-2-oni-johdannaisten valmistamiseksi.

Country Status (16)

Country Link
US (1) US3435005A (fi)
BE (2) BE666274A (fi)
BR (1) BR6242421D0 (fi)
CA (1) CA963004A (fi)
CH (4) CH446362A (fi)
CY (2) CY386A (fi)
DE (8) DE1645903C3 (fi)
DK (2) DK127600B (fi)
FI (4) FI46072C (fi)
FR (1) FR2217M (fi)
GB (5) GB1022645A (fi)
IL (1) IL23813A (fi)
LU (1) LU48964A1 (fi)
MY (3) MY6900102A (fi)
NL (1) NL6508496A (fi)
SE (5) SE322225B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL261058A (fi) * 1960-05-19
DE1795231C3 (de) * 1963-05-29 1978-07-13 American Home Products Corp., New York, N.Y. (V.St.A.) Verfahren zur Herstellung von 5-Aryl-1,2-dihydro -3H-1,4-benzodiazepin-2-on-4-oxyden
BE788899A (fr) * 1971-09-15 1973-01-02 Crc Ricerca Chim Procede de preparation de derives de benzodiazepine-1,4 one-2 utiles notamment comme agents tranquillisants et sedatifs
ES405260A1 (es) * 1972-07-28 1975-07-01 Stabilimenti Chim Farmac Riuni Procedimiento para la preparacion de 3-hidroxi-5-aril-7- sustituidos-1, 3-dihidro-2h-1, 4-benzodiacepin-2-onas.
DE2852606A1 (de) * 1977-12-14 1979-06-21 Gerot Pharmazeutika 3-di-n-propyl-acetoxy-benzodiazepin-2-one und verfahren zu deren herstellung
AT361492B (de) * 1978-12-18 1981-03-10 Gerot Pharmazeutika Verfahren zur herstellung von neuen 3-hydroxy- 1,4-benzodiazepin-2-onen
US4540727A (en) * 1982-10-29 1985-09-10 Raychem Corporation Polyamide compositions
IT1165588B (it) * 1983-03-23 1987-04-22 Medosan Ind Biochimi 1,4 benzodiazepine terapeuticamente attive
US6350870B2 (en) * 2000-03-06 2002-02-26 Teva Pharmaceutical Industreis, Ltd. Process for preparing pure crystalline lorazepam
CN105601576A (zh) * 2016-03-18 2016-05-25 山东新华制药股份有限公司 氯甲西泮的晶型及其制备方法
UA119735C2 (uk) 2018-12-20 2019-07-25 Анатолій Семенович Редер Фармацевтична сполука, спосіб її отримання та застосування як лікарського засобу

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2457224A (en) * 1945-07-03 1948-12-28 Du Pont Preparation of polydioxolane
BE522938A (fi) * 1951-08-22
US3027352A (en) * 1958-02-28 1962-03-27 Celanese Corp Copolymers
NL271273A (fi) * 1960-11-15
BE626151A (fi) * 1961-12-14
US3293219A (en) * 1963-07-10 1966-12-20 Tenneco Chem Polyacetal terpolymers containing randomly recurring groups derived from a methylene-bis-

Also Published As

Publication number Publication date
FI47371B (fi) 1973-07-31
DE1645903A1 (de) 1970-01-02
FR2217M (fr) 1963-12-16
SE368575B (fi) 1974-07-08
SE323080B (fi) 1970-04-27
DE1795509A1 (de) 1972-04-13
FI46849B (fi) 1973-04-02
CY498A (en) 1969-07-01
GB1022645A (en) 1966-03-16
DE1795556B2 (de) 1973-09-13
DE1795558A1 (de) 1971-11-18
DE1795553B2 (de) 1973-10-31
DE1645903B2 (de) 1977-09-01
SE322225B (fi) 1970-04-06
DE1445412A1 (de) 1969-02-27
CH451519A (fr) 1968-05-15
GB1022642A (en) 1966-03-16
DE1795509C3 (de) 1974-04-11
FI46848B (fi) 1973-04-02
DK114514B (da) 1969-07-07
DE1570365B2 (de) 1970-12-23
FI46072C (fi) 1972-12-11
GB1022644A (en) 1966-03-16
BE666274A (fi) 1966-01-03
SE337033B (fi) 1971-07-26
MY6900345A (en) 1969-12-31
CH467790A (de) 1969-01-31
US3435005A (en) 1969-03-25
DE1795556A1 (de) 1972-01-27
CY386A (en) 1967-04-25
DK127600B (da) 1973-12-03
DE1795553C3 (de) 1974-07-18
FI46848C (fi) 1973-07-10
BR6242421D0 (pt) 1973-07-12
DE1570365A1 (de) 1970-01-29
CA963004A (en) 1975-02-18
FI46072B (fi) 1972-08-31
SE335734B (fi) 1971-06-07
DE1795509B2 (de) 1973-09-06
GB1078788A (en) 1967-08-09
LU48964A1 (fi) 1966-01-03
BE621819A (fi)
NL6508496A (fi) 1966-01-03
DE1645904B1 (de) 1970-08-06
DE1795553A1 (de) 1972-02-03
CH417611A (de) 1966-07-31
IL23813A (en) 1969-04-30
CH446362A (de) 1967-11-15
MY6900102A (en) 1969-12-31
DE1795556C3 (de) 1974-04-25
DE1645903C3 (de) 1978-05-03
GB1022643A (en) 1966-03-16
FI47371C (fi) 1973-11-12
MY7000021A (en) 1970-12-31

Similar Documents

Publication Publication Date Title
FI42564C (fi) Menetelmä valmistaa terapeuttisesti vaikuttavia 2-aryyliamino-1,3-diatsasykloalkeeneja
FI46847C (fi) Menetelmä terapeuttisesti vaikuttavien 3-asetoksi-5-aryyli-3H-1,2-dihy dro-1,4-bentsodiatsepiini-2-onien valmistamiseksi.
OA03371A (fr) Procédé de préparation de médicaments antériques.
FI46849C (fi) Menetelmä terapeuttisesti vaikuttavien 3-hydroksi-3H-1,2-dihydro-1,4-b entsodiatsepiini-2-onien valmistamiseksi.
DK117351B (da) Fremgangsmåde til fremstilling af terapeutisk aktive indoliziner.
FI46069C (fi) Menetelmä terapeuttisesti käytettävän 1-R-2-formyyli-5-nitroimidatsoli n valmistamiseksi.
FI45180C (fi) Menetelmä terapeuttisesti arvokkaiden sulfonanilidien valmistamiseksi.
FI46507C (fi) Menetelmä uuden terapeuttisesti käytettävän 1-metyyli-N-karbobentsoksi dihydrolysergamiinin valmistamiseksi.
DK122760B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme 4-alkoxy-3,5-dimethoxybenzamider.
DK108227C (da) Fremgangsmåde til fremstilling af 3-carbonhydridoxy-17α-halogenethinyl-19-nor-3,5-androstadien-17β-oler.
DK112161B (da) Fremgangsmåde til fremstilling af et gærpræparat til farmaceutisk anvendelse.
FI46621C (fi) Menetelmä terapeuttisesti vaikuttavien 5-fenyyli-3H-1,4-bentsodiatsepi inijohdannaisten valmistamiseksi.
DK117488C (da) Fremgangsmåde til fremstilling af terapeutisk aktive 2α-3α-epithio-5α-androstaner.
FI45760C (fi) Menetelmä 2-kloori-4-atsafentiatsiinin valmistamiseksi, joka on tärkeä välituote lääkeaineiden valmistamiseksi.
FI45954C (fi) Menetelmä terapeuttisesti vaikuttavien bentseenisulfonyylivirtsa-ainei den valmistamiseksi.
FI46066C (fi) Analogiamenetelmä terapeuttisesti vaikuttavien N,N-dimetyyliamino-etyy li-14beta-hydroksi-5beta-pregn-20-eeni-21-karboksylaattien valmistamis eksi.
DK103352C (da) Fremgangsmåde til fremstilling af quinolizinderivater.
FI45047C (fi) Menetelmä terapeuttisesti käytettävän 2-sulfaniiliamido-5-metoksipyrim idiinin valmistamiseksi.
DK105204C (da) Fremgangsmåde til fremstilling af terapeutisk verkende salte af kinolinforbindelser.
DK117960B (da) Fremgangsmåde til fremstilling af sulfobetainer.
FI49722C (fi) Menetelmä terapeuttisesti vaikuttavien 3-karbonihappoamidokinoksaliini -di-N-oksidien-(1,4) valmistamiseksi.
DK109324C (da) Fremgangsmåde til fremstilling af 1-brom-chlor-2,2-difluorpropan.
DK115398B (da) Fremgangsmåde til fremstilling af N-sulfonyl-chlormyresyreamidiner.
GR22873B (el) Μεθοδος δια την παρασκευην θεραπευτικως ενεργων ενωσεων.
FI42434C (fi) Menetelmä uusien, terapeuttisesti aktiivisten alfa-fenyylipropionihappo-johdannaisten valmistamiseksi